Mineral and bone disorder (MBD) in chronic kidney disease (CKD) comprises abnormalities in mineral metabolites and hormones, including serum calcium, phosphate, fibroblast growth factor-23, and parathyroid hormone (PTH), as well as bone disorder and vascular calcification [1]. This evidence concerns the gene PTH and Marchiafava-Bignami disease.